终末期患者谵妄的研究进展

doi:10.3761/j.issn.0254-1769.2021.02.024

摘要/Abstract

摘要：

随着安宁疗护在中国的发展,患者生命末期生存质量得到越来越多的关注,终末期患者症状控制的研究日益增加。谵妄是终末期患者最常见的症状之一,具有发生率高、漏诊率高、危险性高等特点,延长了住院周期,增加了经济负担,也增加了跌倒、压力性损伤、意外拔管等风险,加速了死亡进程。尽管提倡以跨学科协作团队管理谵妄,但管理效果仍不理想,缺少对谵妄的正确认知、评估与干预,降低了安宁疗护照护质量。该文综述终末期患者谵妄特点、国内外常用谵妄评估工具、危险因素、药物及非药物干预措施,以期为终末期患者制订有效的谵妄管理方案提供借鉴。

关键词: 安宁疗护, 终末期患者, 谵妄, 综述

Abstract:

With the development of hospice care,the quality of life at the end of life receives much attention,and the research on the symptom control of terminal-stage patients is increasing. Delirium is one of the most common symptoms in terminal-stage patients,which is characterised by high incidence,high rate of missed diagnosis and high risks. Delirium extends the hospitalization cycle,increases the economic burden,increases the risk of falling,stress injury and accidental extubation,and accelerates the death process. Although an interdisciplinary team is advocated to manage delirium,the effect still remains unsatisfactory with inadequate cognition,evaluation and intervention,reducing the quality of hospice care.The paper reviews the characteristics of delirium,commonly used assessment tools,risk factors,drug and non-drug interventions for the development of effective delirium management programs for terminal-stage patients.

Key words: Hospice Care, End-of-Life Patients, Delirium, Review

樊溶榕, 李旭英, 魏涛, 黄新娟, 谭艳, 李金花. 终末期患者谵妄的研究进展[J]. 中华护理杂志, 2021, 56(2): 295-299.

FAN Rongrong, LI Xuying, WEI Tao, HUANG Xinjuan, TAN Yan, LI Jinhua. Research progress on delirium in end-of-life patients with hospice care[J]. Chinese Journal of Nursing, 2021, 56(2): 295-299.

参考文献 42

[1]	中国生命关怀协会. 卫计委:临终关怀服务纳入医保长护险报销中央财政投30亿各项优惠政策出台[EB/OL].( 2018-03-05)[2019-12-21]. http://www.cnaflc.org/lzgh/14234.jhtml.
	Chinese Association For Life Care. The Center of Health Supervision National Health Commission of the People’s Republic of China:the central government provided 3 billions yuan in preferential policies to include hospice care in reimbursement of long-term medical care insurance[EB/OL]. ( 2018 -03-05)[2019-12-21]. http://www.cnaflc.org/lzgh/14234.jhtml.
[2]	Neufeld KJ, Thomas C . Delirium:definition,epidemiology,and dia-gnosis[J]. J Clin Neurophysiol, 2013,30(5):438-442.
[3]	Finucane AM, Lugton J, Kennedy C , et al. The experiences of caregivers of patients with delirium,and their role in its management in palliative care settings:an integrative literature review[J]. Psycho-Oncology, 2017,26(3):291-300.
[4]	Mercadante S, Masedu F, Balzani I , et al. Prevalence of delirium in advanced cancer patients in home care and hospice and outcomes after 1 week of palliative care[J]. Support Care Cancer, 2018,26(3):913-919.
[5]	Prayce R, Quaresma F, Neto IG . Delirium:the 7th vital sign?[J]. Acta Med Port, 2018,31(1):51-58.
[6]	Seiler A, Schubert M, Hertler C , et al. Predisposing and precipitating risk factors for delirium in palliative care patients[J]. Pall Supp Care, 2020,18(4):437-446.
[7]	Barnes CJ, Webber C, Bush SH , et al. Rating delirium severity using the Nursing Delirium Screening Scale:a validation study in patients in palliative care[J]. J Pain Symptom Manage, 2019,58(4):4-7.
[8]	Watt CL, Momoli F, Ansari MT , et al. The incidence and pre-valence of delirium across palliative care settings:a systematic review[J]. Palliat Med, 2019,33(8):865-877.
[9]	Agar M, Draper B, Phillips PA , et al. Making decisions about delirium:a qualitative comparison of decision making between nurses working in palliative care,aged care,aged care psychiatry,and oncology[J]. Palliat Med, 2012,26(7):887-896.
[10]	Bush SH, Lawlor PG, Ryan K , et al. Delirium in adult cancer patients:ESMO Clinical Practice Guidelines[J]. Ann Oncol, 2018, 29:iv143-iv165.
[11]	Mercadante S, Adile C, Ferrera P , et al. Symptom expression in patients with advanced cancer admitted to an acute supportive/palliative care unit with and without delirium[J]. The Oncol, 2019,24(6):358-364.
[12]	李海涛, 许金凤, 黎春华 . 姑息治疗晚期癌症患者的预后状况及其影响因素分析[J]. 实用癌症杂志, 2014,29(6):724-726.
	Li HT, Xu JF, Li CH . Study of prognosis of palliative care for patients with advanced cancer and its influencing factors[J]. Pract J Cancer, 2014,29(6):724-726.
[13]	Agar M, Shirley H . Delirium at the end of life[J]. Med Clin North Am, 2020,104(3):491-501.
[14]	Delirium:diagnosis,prevention and management[EB/OL].( 2019 - 03-14)[2020-02-21]. https://www.nice.org.uk/search?q=Delirium%3A+diagnosis%2C+prevention+and+management.
[15]	Heinrich TW, Kato H, Emanuel C , et al. Improving the validity of nurse-based delirium screening:a head-to-head comparison of nursing delirium-screening scale and short confusion assessment method[J]. Psychosomatics, 2019,60(2):172-178.
[16]	Bush SH, Tierney S, Lawlor PG . Clinical assessment and management of delirium in the palliative care setting[J]. Drugs, 2017,77(15):1623-1643.
[17]	Fabbri RMA, Moreira MA, Garrido R , et al. Validity and reliability of the Portuguese version of the Confusion Assessment Method(CAM)for the detection of delirium in the elderly[J]. Arq Neuro-Psiquiatr, 2001,59(2A):175-179.
[18]	Han JH, Wilson A, Vasilevskis EE , et al. Diagnosing delirium in older emergency department patients:validity and reliability of the delirium triage screen and the brief confusion assessment method[J]. Ann Emerg Med, 2013,62(5):457-465.
[19]	Wilson JE, Boehm L, Samuels LR , et al. Use of the brief con-fusion assessment method in a veteran palliative care population:a pilot validation study[J]. Pall Supp Care, 2019,17(5):569-573.
[20]	O’Sullivan R, Meagher D, Leonard M , et al. A comparison of the revised Delirium Rating Scale(DRS-R98)and the Memorial Delirium Assessment Scale(MDAS)in a palliative care cohort with DSM-IV delirium[J]. Pall Supp Care, 2015,13(4):937-944.
[21]	Schuurmans MJ, Shortridge-Baggett LM, Duursma SA . The De-lirium Observation Screening Scale:a screening instrument for delirium[J]. Res Theory Nurs Pract, 2003,17(1):31-50.
[22]	Neefjes ECW, van der Vorst MJDL, Boddaert MSA , et al. Accuracy of the Delirium Observational Screening Scale(DOS)as a screening tool for delirium in patients with advanced cancer[J]. BMC Cancer, 2019,19:160.
[23]	Breitbart W, Rosenfeld B, Roth A , et al. The memorial delirium assessment scale[J]. J Pain Symptom Manag, 1997,13(3):128-137.
[24]	Kang B, Kim YJ, Suh SW , et al. Delirium and its consequences in the specialized palliative care unit:validation of the Korean version of Memorial Delirium Assessment Scale[J]. Psycho-Oncology, 2019,28(1):160-166.
[25]	Klankluang W, Pukrittayakamee P, Atsariyasing W , et al. Validity and reliability of the memorial delirium assessment scale-Thai version(MDAS-T) for assessment of delirium in palliative care patients[J]. The Oncol, 2020,25(2):335-340.
[26]	Leonard MM, Nekolaichuk C, Meagher DJ , et al. Practical assessment of delirium in palliative care[J]. J Pain Symptom Manag, 2014,48(2):176-190.
[27]	冯勤, 李玲, 马望 , 等. 癌症终末期患者谵妄的发生情况及影响因素分析[J]. 中华护理杂志, 2019,54(2):238-243.
	Feng Q, Li L, Ma W , et al. Analysis of the occurrence and influencing factors of delirium in terminal cancer patients[J]. Chin J Nurs, 2019,54(2):238-243.
[28]	enel G, Uysal N, Oguz G , et al. Delirium frequency and risk factors among patients with cancer in palliative care unit[J]. Am J Hosp Palliat Care, 2017,34(3):282-286.
[29]	Díaz GV, López PM, Zuriarrain RY . Prevalence of delirium using the Memorial Delirium Assessment Scale(MDAS)in advanced oncology patients admitted to a Palliative Care Unit. Risk factors,reversibility and treatment received[J]. Medicina Paliativa, 2018,25(4):245-254.
[30]	Agar MR, Lawlor PG, Quinn S , et al. Efficacy of oral risperidone,haloperidol,or placebo for symptoms of delirium among patients in palliative care:a randomized clinical trial[J]. JAMA Intern Med, 2017,177(1):34-42.
[31]	Gaertner J, Eychmueller S, Leyhe T , et al. Benzodiazepines and/or neuroleptics for the treatment of delirium in palliative care?—a critical appraisal of recent randomized controlled trials[J]. Ann Palliat Med, 2019,8(4):504-515.
[32]	Hui D, Frisbee-Hume S, Wilson A , et al. Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care[J]. JAMA, 2017,318(11):1047.
[33]	Bush SH, Lacaze-Masmonteil N, Mcnamara-Kilian MT , et al. The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium:study protocol for a randomized controlled trial[J]. Trials, 2016,17:399.
[34]	Felton MA, Jarrett JB, Hoffmaster R , et al. Comparison of halo-peridol,non-haloperidol antipsychotics,and no pharmacotherapy for the management of delirium in an inpatient geriatric palliative care population[J]. J Pain Palliat Care Pharmaco-ther, 2018,32(2/3):141-148.
[35]	Gärtner J, Büche D, Camartin C . Delirium in palliative care:evidence and practice[J]. Therapeutische Umschau, 2018,75(2):91-100.
[36]	Reith S . Nicht pharmakologische und pharmakologische therapie des delirs[J]. Dtsch Med Wochenschr, 2019,144(23):1629-1635.
[37]	Abraha I, Trotta F, Rimland JM , et al. Efficacy of non-pharmacological interventions to prevent and treat delirium in older patients:a systematic overview. The SENATOR project ONTOP series[J]. PLoS One, 2015,10(6):e0123090.
[38]	Salvi F, Young J, Lucarelli M , et al. Non-pharmacological approaches in the prevention of delirium[J]. Eur Geriatr Med, 2020,11(1):71-81.
[39]	Gagnon P, Allard P, Gagnon B , et al. Delirium prevention in terminal cancer:assessment of a multicomponent intervention[J]. Psycho-Oncology, 2012,21(2):187-194.
[40]	李真, 李奇, 李尊柱 , 等. ICU患者亚谵妄综合征患病率及危险因素的系统评价[J]. 中华护理杂志, 2020,55(2):288-293.
	Li Z, Li Q, Li ZZ , et al. Prevalence and risk factors of subsyndromal delirium among adult intensive care unit patients:a systematic review[J]. Chin J Nurs, 2020,55(2):288-293.
[41]	盛美丽, 钱振华, 陆雯等. 环境管理结合早期运动在重症加强护理病房术后谵妄患者中的应用[J]. 中国基层医药, 2020,27(03):368-370.
	Sheng ML, Qian ZH, Lu W , et al. Application of environmental management combined with early excercise in postoperative patients with delirium in intensive care unit[J]. Chin J Prim Med Pharm. 2020,27(03):368-370.
[42]	郭慧琦, 沈蕴之, 蒋红 , 等. 危重症患者三级谵妄管理流程的制订及应用效果评价[J]. 中华护理杂志, 2019,54(3):332-337.
	Guo HQ, Shen YZ, Jiang H , et al. Development and application of the three-stage delirium management process in critical patients[J]. Chin J Nurs, 2019,54(3):332-337.